The Hu-M™ Technology

Development of new interventions against human disease requires complex in vivo analysis in pre-clinical animal models. However, because of the significant differences between human and animal biological systems, pre-clinical animal models have been unable to accurately predict the effects of novel therapeutics on human diseases.

HuMurine Technologies was founded in 2008 by Dr. Gerold Feuer, a pioneer in the field of humanized mouse models with the mission of making humanized mouse models more accessible for academic and commercial clients.  Since it’s inception, HuMurine has worked closely with both academic and commercial clients to develop and standardize a better preclinical humanized mouse model.  HuMurine Technologies’ work culminated in the launch of the Hu-M™ CIEA NOG® mouse model.  Based on this novel platform, HuMurine has recently announced the launch of four new preclinical models to cater to the specific needs of clients seeking to perform studies relating to cancer, infectious disease and immunotherapy.